J Endocr Surg.  2019 Sep;19(3):85-87. 10.16956/jes.2019.19.3.85.

Patient Choice and Adherence to Active Surveillance for Low-risk Thyroid Cancer

• Sun H
• Pino A
• Mastrojeni C
• Mangraviti A
• Dionigi G

• KMID: 2458706
• DOI: http://doi.org/10.16956/jes.2019.19.3.85

Abstract

Currently, treatment decisions for low-risk micro thyroid cancer (TC) are arguably some of the most challenging in thyroidology. Active surveillance has emerged as an important option for low-risk micro TC. Multiple patient and physician factors affect the final selection, adherence to active surveillance or definitive conservative surgery. While baseline clinical criteria are used to identify candidates for this approach, it is important to identify and understand other forces that may influence the management of low-risk micro TC with active surveillance.

Keyword

Decision making; Patient compliance; Physician-patient relations; Thyroid neoplasms

MeSH Terms

Decision Making
Humans
Patient Compliance
Physician-Patient Relations
Thyroid Gland*
Thyroid Neoplasms*

Reference

1. Sugitani I, Ito Y, Miyauchi A, Imai T, Suzuki S. Active surveillance versus immediate surgery: questionnaire survey on the current treatment strategy for adult patients with low-risk papillary thyroid microcarcinoma in Japan. Thyroid. 2019.

2. Cho SJ, Suh CH, Baek JH, Chung SR, Choi YJ, Chung KW, et al. Active surveillance for small papillary thyroid cancer: a systematic review and meta-analysis. Thyroid. 2019.

3. Paparodis RD, Bantouna D, Imam S, Jaume JC. The non-interventional approach to papillary thyroid microcarcinomas. An “active surveillance” dilemma. Surg Oncol. 2019; 29:113–117.

4. Nickel B, Brito JP, Moynihan R, Barratt A, Jordan S, McCaffery K. Patients' experiences of diagnosis and management of papillary thyroid microcarcinoma: a qualitative study. BMC Cancer. 2018; 18:242.

5. Miyauchi A, Kudo T, Ito Y, Oda H, Yamamoto M, Sasai H, et al. Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentation. Surgery. 2019; 165:25–30.

6. Sun H, Dionigi G. Active surveillance for micro-papillary thyroid carcinoma: who are candidates, how should they be followed, when should they be treated, and what are the clinical and pathologic outcomes after delayed intervention. Surgery. 2018; 163:1325–1329.

7. Shaha AR, Tuttle RM. Editorial: risk of disease progression during active surveillance of papillary thyroid cancer. Surgery. 2018; 163:53–54.

8. Vodermaier A, Linden W, Rnic K, Young SN, Ng A, Ditsch N, et al. Prospective associations of depression with survival: a population-based cohort study in patients with newly diagnosed breast cancer. Breast Cancer Res Treat. 2014; 143:373–384.